Chronic inflammation in the pancreas and salivary glands - Lessons from similarities and differences in pathophysiology and treatment modalities

Z. Rakonczay, János Vág, Anna Földes, Krisztina Nagy, Ákos Nagy, P. Hegyi, G. Varga

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The pancreas and salivary glands have similar anatomical structures and physiological functions producing bicarbonate-rich fluid containing digestive enzymes and other components to be delivered into the gut. Despite these similarities, the two organs are also different in numerous respects, especially regarding the inflammatory diseases affecting them. This article will summarize the patho-physiology and current and potential pharmacological treatments of chronic inflammatory diseases such as chronic pancreatitis, autoimmune pancreatitis, Sjögren's syndrome and irradiation-induced salivary gland atrophy. Despite the differences, in both organs the inflammatory process is accompanied by epithelial tissue destruction and fibrosis. Both in pancreatic and in salivary research, an important task is to stop or even reverse this process. The utilization of stem/progenitor cell populations previously identified in these organs and the application of mesenchymal stem cells are very promising for such regenerative purposes. In addition, gene therapy and tissue engineering research progressively advance and have already yielded clinically beneficial preliminary results for salivary gland diseases. For the hard-to-access, hard-to-regenerate pancreas these developments may also offer new solutions, especially since salivary and pancreatic progenitors are very similar in characteristics and may be mutually useful to regenerate the respective other organ as well. These novel developments could be of great significance and may bring new hope for patients since currently used therapeutic protocols in salivary and in pancreatic chronic inflammatory diseases offer primarily symptomatic treatments and limited beneficial outcome.

Original languageEnglish
Pages (from-to)1104-1120
Number of pages17
JournalCurrent Pharmaceutical Design
Volume20
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Salivary Glands
Pancreas
Inflammation
Chronic Disease
Stem Cells
Salivary Gland Diseases
Chronic Pancreatitis
Tissue Engineering
Bicarbonates
Mesenchymal Stromal Cells
Research
Pancreatitis
Genetic Therapy
Atrophy
Fibrosis
Therapeutics
Epithelium
Pharmacology
Enzymes
Population

Keywords

  • Artificial gland
  • Atrophy
  • Autoimmune pancreatitis
  • Chronic
  • Chronic pancreatitis
  • Development
  • Fibrosis
  • Fibrosis epithelium
  • Head and neck cancer
  • Inflammation
  • Mesenchyme
  • Pancreas
  • Progenitor
  • Radiation therapy
  • Salivary gland
  • Sjögren's syndrome
  • Stem cell
  • Tissue engineering

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Medicine(all)

Cite this

Chronic inflammation in the pancreas and salivary glands - Lessons from similarities and differences in pathophysiology and treatment modalities. / Rakonczay, Z.; Vág, János; Földes, Anna; Nagy, Krisztina; Nagy, Ákos; Hegyi, P.; Varga, G.

In: Current Pharmaceutical Design, Vol. 20, No. 7, 2014, p. 1104-1120.

Research output: Contribution to journalArticle

@article{b9c90bdafdee4875bad0f5a52ab0f41d,
title = "Chronic inflammation in the pancreas and salivary glands - Lessons from similarities and differences in pathophysiology and treatment modalities",
abstract = "The pancreas and salivary glands have similar anatomical structures and physiological functions producing bicarbonate-rich fluid containing digestive enzymes and other components to be delivered into the gut. Despite these similarities, the two organs are also different in numerous respects, especially regarding the inflammatory diseases affecting them. This article will summarize the patho-physiology and current and potential pharmacological treatments of chronic inflammatory diseases such as chronic pancreatitis, autoimmune pancreatitis, Sj{\"o}gren's syndrome and irradiation-induced salivary gland atrophy. Despite the differences, in both organs the inflammatory process is accompanied by epithelial tissue destruction and fibrosis. Both in pancreatic and in salivary research, an important task is to stop or even reverse this process. The utilization of stem/progenitor cell populations previously identified in these organs and the application of mesenchymal stem cells are very promising for such regenerative purposes. In addition, gene therapy and tissue engineering research progressively advance and have already yielded clinically beneficial preliminary results for salivary gland diseases. For the hard-to-access, hard-to-regenerate pancreas these developments may also offer new solutions, especially since salivary and pancreatic progenitors are very similar in characteristics and may be mutually useful to regenerate the respective other organ as well. These novel developments could be of great significance and may bring new hope for patients since currently used therapeutic protocols in salivary and in pancreatic chronic inflammatory diseases offer primarily symptomatic treatments and limited beneficial outcome.",
keywords = "Artificial gland, Atrophy, Autoimmune pancreatitis, Chronic, Chronic pancreatitis, Development, Fibrosis, Fibrosis epithelium, Head and neck cancer, Inflammation, Mesenchyme, Pancreas, Progenitor, Radiation therapy, Salivary gland, Sj{\"o}gren's syndrome, Stem cell, Tissue engineering",
author = "Z. Rakonczay and J{\'a}nos V{\'a}g and Anna F{\"o}ldes and Krisztina Nagy and {\'A}kos Nagy and P. Hegyi and G. Varga",
year = "2014",
doi = "10.2174/13816128113199990415",
language = "English",
volume = "20",
pages = "1104--1120",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

TY - JOUR

T1 - Chronic inflammation in the pancreas and salivary glands - Lessons from similarities and differences in pathophysiology and treatment modalities

AU - Rakonczay, Z.

AU - Vág, János

AU - Földes, Anna

AU - Nagy, Krisztina

AU - Nagy, Ákos

AU - Hegyi, P.

AU - Varga, G.

PY - 2014

Y1 - 2014

N2 - The pancreas and salivary glands have similar anatomical structures and physiological functions producing bicarbonate-rich fluid containing digestive enzymes and other components to be delivered into the gut. Despite these similarities, the two organs are also different in numerous respects, especially regarding the inflammatory diseases affecting them. This article will summarize the patho-physiology and current and potential pharmacological treatments of chronic inflammatory diseases such as chronic pancreatitis, autoimmune pancreatitis, Sjögren's syndrome and irradiation-induced salivary gland atrophy. Despite the differences, in both organs the inflammatory process is accompanied by epithelial tissue destruction and fibrosis. Both in pancreatic and in salivary research, an important task is to stop or even reverse this process. The utilization of stem/progenitor cell populations previously identified in these organs and the application of mesenchymal stem cells are very promising for such regenerative purposes. In addition, gene therapy and tissue engineering research progressively advance and have already yielded clinically beneficial preliminary results for salivary gland diseases. For the hard-to-access, hard-to-regenerate pancreas these developments may also offer new solutions, especially since salivary and pancreatic progenitors are very similar in characteristics and may be mutually useful to regenerate the respective other organ as well. These novel developments could be of great significance and may bring new hope for patients since currently used therapeutic protocols in salivary and in pancreatic chronic inflammatory diseases offer primarily symptomatic treatments and limited beneficial outcome.

AB - The pancreas and salivary glands have similar anatomical structures and physiological functions producing bicarbonate-rich fluid containing digestive enzymes and other components to be delivered into the gut. Despite these similarities, the two organs are also different in numerous respects, especially regarding the inflammatory diseases affecting them. This article will summarize the patho-physiology and current and potential pharmacological treatments of chronic inflammatory diseases such as chronic pancreatitis, autoimmune pancreatitis, Sjögren's syndrome and irradiation-induced salivary gland atrophy. Despite the differences, in both organs the inflammatory process is accompanied by epithelial tissue destruction and fibrosis. Both in pancreatic and in salivary research, an important task is to stop or even reverse this process. The utilization of stem/progenitor cell populations previously identified in these organs and the application of mesenchymal stem cells are very promising for such regenerative purposes. In addition, gene therapy and tissue engineering research progressively advance and have already yielded clinically beneficial preliminary results for salivary gland diseases. For the hard-to-access, hard-to-regenerate pancreas these developments may also offer new solutions, especially since salivary and pancreatic progenitors are very similar in characteristics and may be mutually useful to regenerate the respective other organ as well. These novel developments could be of great significance and may bring new hope for patients since currently used therapeutic protocols in salivary and in pancreatic chronic inflammatory diseases offer primarily symptomatic treatments and limited beneficial outcome.

KW - Artificial gland

KW - Atrophy

KW - Autoimmune pancreatitis

KW - Chronic

KW - Chronic pancreatitis

KW - Development

KW - Fibrosis

KW - Fibrosis epithelium

KW - Head and neck cancer

KW - Inflammation

KW - Mesenchyme

KW - Pancreas

KW - Progenitor

KW - Radiation therapy

KW - Salivary gland

KW - Sjögren's syndrome

KW - Stem cell

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=84895133920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84895133920&partnerID=8YFLogxK

U2 - 10.2174/13816128113199990415

DO - 10.2174/13816128113199990415

M3 - Article

VL - 20

SP - 1104

EP - 1120

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 7

ER -